BioInvent and SkylineDx to Collaborate on Patient Stratification to Maximize Impact of Treatment with BI-1206

LUND, Sweden, March 24, 2020 /PRNewswire/ — BioInvent International AB (“BioInvent”) (OMXS: BINV) today announces an agreement with SkylineDx to characterize the gene expression and immunological …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
730